Riboflavin laurate nanosuspensions as an intramuscular injection for long-term riboflavin supplementation

International Journal of Pharmaceutics

Volumn 450, Issue 1-2, 2013, Pages 338-344

  Du, Lina ^a   Li, Guanglong ^a,b   Jin, Yiguang ^a,b   Wang, Lin ^a,b   Xu, Qishou ^a   Dong, Junxing ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b HENAN UNIVERSITY   (China)

Author keywords

Molecular self assembly; Nanosuspensions; Nutritional supplements; Prodrug; Riboflavin

Indexed keywords

N,N DIMETHYLFORMAMIDE; NANOMATERIAL; POLOXAMER; RIBOFLAVIN; RIBOFLAVIN LAURATE; SOLVENT; TREHALOSE; UNCLASSIFIED DRUG; WATER;

AIR; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG FORMULATION; DRUG METABOLISM; DRUG SOLUBILITY; FOOD INTAKE; MALE; MONOLAYER CULTURE; NANOSUSPENSION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SUPPLEMENTATION; SUSPENSION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; DIETARY SUPPLEMENTS; INJECTIONS, INTRAMUSCULAR; LAURATES; MALE; METHOTREXATE; NANOSTRUCTURES; ORAL ULCER; RATS; RATS, SPRAGUE-DAWLEY; RIBOFLAVIN; RIBOFLAVIN DEFICIENCY; SUSPENSIONS; VITAMIN B COMPLEX;

EID: 84878361810     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.04.005     Document Type: Article

References (38)

1. A. Badart-Smook, A.C. van Houwelingen, M.D. Al, A.D. Kester, and G. Hornstra Fetal growth is associated positively with maternal intake of riboflavin and negatively with maternal intake of linoleic acid J. Am. Diet. Assoc. 97 1997 867 870
2. C.J. Bates Bioavailability of riboflavin Eur. J. Clin. Nutr. 51 1997 S38 S42
3. N. Bergstrand, and K. Edwards Effects of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers on structure and stability of liposomal dioleoylphosphatidylethanolamine J. Colloid Interface Sci. 276 2004 400 407
4. F. Depeint, W.R. Bruce, N. Shangari, R. Mehta, and P.J. O'Brien Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism Chem. Biol. Interact. 163 2006 94 112
5. S. Dreizen, K.B. McCredie, M.J. Keating, and B.S. Andersson Nutritional deficiencies in patients receiving cancer chemotherapy Postgrad. Med. 87 1990 170
6. J.M. Dunn Nutritional abnormalities in HIV/AIDS HIV Hotline 8 1998 11 12
7. A.B. Foraker, C.M. Khantwal, and P.W. Swaan Current perspectives on the cellular uptake and trafficking of riboflavin Adv. Drug Deliv. Rev. 55 2003 1467 1483
8. M.H. Gaber, M.M. Ghannam, S.A. Ali, and W.A. Khalil Interaction of doxorubicin with phospholipid monolayer and liposomes Biophys. Chem. 70 1998 233 239
9. R. Gröning, C. Cloer, M. Georgarakis, and R.S. Müller Compressed collagen sponges as gastroretentive dosage forms: in vitro and in vivo studies Eur. J. Pharm. Sci. 30 2007 1 6
10. J. Hamdani, J. Goole, A.J. Moes, and K. Amighi In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process Int. J. Pharm. 323 2006 86 92
11. B. Heurtault, P. Saulnier, B. Pech, J.-E. Proust, and J.-P. Benoit Physico-chemical stability of colloidal lipid particles Biomaterials 24 2003 4283 4300
12. Y. Jin Nanotechnology in pharmaceutical manufacturing S.C. Gad, Pharmaceutical Manufacturing Handbook: Production and Processes 2008 John Wiley & Sons, Inc. Hoboken, NJ 1249 1288
13. Y. Jin, P. Ai, R. Xin, and D. Chen Morphological transformation of self-assembled nanostructures prepared from cholesteryl acyl didanosine and the optimal formulation of nanoparticulate systems: effects of solvents, acyl chain length and poloxamer 188 J. Colloid Interface Sci. 326 2008 275 282
14. Y. Jin, L. Tong, P. Ai, M. Li, and X. Hou Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN) Int. J. Pharm. 309 2006 199 207
15. Y. Jin, R. Xin, P. Ai, and D. Chen Self-assembled drug delivery systems. 2. Cholesteryl derivatives of antiviral nucleoside analogues: synthesis properties and the vesicle formation Int. J. Pharm. 350 2008 330 337
16. Y. Jin, R. Xin, L. Tong, L. Du, and M. Li Combination anti-HIV therapy with the self-assemblies of an asymmetric bolaamphiphilic zidovudine/didanosine prodrug Mol. Pharm. 8 2011 867 876
17. T. Kamilya, P. Pal, and G.B. Talapatra Interaction and incorporation of ovalbumin with stearic acid monolayer: Langmuir-Blodgett film formation and deposition Colloids Surf. B: Biointerfaces 58 2007 137 144
18. K. Kostarelos, T.F. Tadros, and P.F. Luckham Physical conjugation of tri-block copolymers to liposomes toward the construction of sterically stabilized vesicle systems Langmuir 15 1999 369 376
19. G. Levy, and W.J. Jusko Factors affecting the absorption of riboflavin in man J. Pharm. Sci. 55 1966 285 289
20. J. Li, K.D. Caldwell, and N. Rapoport Surface properties of pluronic-coated polymeric colloids Langmuir 10 1994 4475 4482
21. X. Liang, G. Mao, and K.Y.S. Ng Effect of chain lengths of PEO-PPO-PEO on small unilamellar liposome morphology and stability: an AFM investigation J. Colloid Interface Sci. 285 2005 360 372
22. F. Liu, J.-Y. Park, Y. Zhang, C. Conwell, Y. Liu, S.R. Bathula, and L. Huang Targeted cancer therapy with novel high drug-loading nanocrystals J. Pharm. Sci. 99 2010 3542 3551
23. Y. Liu, P. Xie, D. Zhang, and Q. Zhang A mini review of nanosuspensions development J. Drug Target. 20 2012 209 223
24. K.C. Manthey, R. Rodriguez-Melendez, J.T. Hoi, and J. Zempleni Riboflavin deficiency causes protein and DNA damage in HEPG2 cells, triggering arrest in G1 phase of the cell cycle J. Nutr. Biochem. 17 2006 250 256
25. S.A. Maskarinec, J. Hannig, R.C. Lee, and K.Y.C. Lee Direct observation of poloxamer 188 insertion into lipid monolayers Biophys. J. 82 2002 1453 1459
26. S.A. Maskarinec, G. Wu, and K.Y.C. Lee Membrane sealing by polymers Ann. N.Y. Acad. Sci. 1066 2005 310 320
27. A.B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler Reporting results of cancer treatment Cancer 47 1981 207 214
28. T. Minagawa, Y. Kohno, T. Suwa, and A. Tsuji Species differences in hydrolysis of isocarbacyclin methyl ester (TEI-9090) by blood esterases Biochem. Pharmacol. 49 1995 1361 1365
29. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 1 12
30. M.G. Sarpietro, F. Rocco, D. Micieli, S. Ottimo, M. Ceruti, and F. Castelli Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface Int. J. Pharm. 395 2010 167 173
31. R. Sedev, R. Steitz, and G.H. Findenegg The structure of PEO-PPO-PEO triblock copolymer at the water/air interface Phys. B 315 2002 267 272
32. D.S. Singare, S. Marella, K. Gowthamrajan, G.T. Kulkarni, R. Vooturi, and P.S. Rao Optimization of formulation and process variable of nanosuspension: an industrial perspective Int. J. Pharm. 402 2010 213 220
33. L.-D. Wang, F.-Y. Zhou, and X.-M. Li Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54 Nat. Genet. 42 2010 759 763
34. Y. Wang, Q. Wang, H. Zhang, J. Ren, F. Wang, and Q. Xu Protective effects of riboflavin laurate on oral mucosa during chemotherapy in rats Infect. Inflamm. Repair 8 2007 26 29
35. G. Wu, J. Majewski, C. Ege, K. Kjaer, M.J. Weygand, and K.Y.C. Lee Interaction between lipid monolayers and poloxamer 188: an X-ray reflectivity and diffraction study Biophys. J. 89 2005 3159 3173
36. Xu, Q.; Wang, L.; Tong, C.; Guo, C.; Lv, Q.; Yun, L.; Dai, L.; Sun, M.; 2004. A Riboflavin Derivative and its Manufacture and Uses, CN.
37. H. Yao, L. Xu, F. Han, X. Che, Y. Dong, M. Wei, J. Guan, X. Shi, and S. Li A novel riboflavin gastro-mucoadhesive delivery system based on ion-exchange fiber Int. J. Pharm. 364 2008 21 26
38. H. Yao, H. Yao, J. Zhu, J. Yu, and L. Zhang Preparation and evaluation of a novel gastric floating alginate/poloxamer inner-porous beads using foam solution Int. J. Pharm. 422 2012 211 219